This contract opportunity involves the procurement of biomedical equipment for health centers in Central Macedonia, Greece. The total value of the contract is €138,250. Suppliers are invited to submit their bids by September 19, 2025. The procurement is managed by the Ministry of Health. For more de
Tender closed on 19 Sept 2025. Awaiting award.
This contract involves selecting a supplier for the delivery of medical equipment and apparatus needed for psychiatric care facilities in Bulgaria. The initiative is part of investment C12 I3: 'Modernization of Psychiatric Care' under the Recovery and Resilience Plan of Bulgaria. The goal is to enha
This contract involves providing comprehensive insurance services for healthcare institutions in Croatia. The services include property insurance against all risks, earthquake insurance, and liability insurance. The total value of the contract is approximately €17,615,071.32. Suppliers interested in
The Ministry of Health in Cyprus is seeking suppliers for the procurement of 'Naglazyme', a medication used for digestive system and metabolism disorders. The total value of this contract is €1,872,000. Suppliers interested in this opportunity can find more details on the TED platform. The awarded s
This contract involves the supply of a hypercaloric solution intended for enteral feeding. The Ministry of Health of Cyprus is seeking suppliers to provide this essential nutritional product. The total value of the contract is €467,100, and the deadline for submissions is January 22, 2026. Intereste
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
